Helexva
Pittsburgh
About Helexva
Helexva operates as a biotech company that specializes in treatment for fatal neurodegenerative diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $2.2M
- Funding stage: Seed
- Last round: Seed (Mar 2024)
Industries & Categories
Biotechnology, Genetics, Health Care, Neuroscience
Canonical: https://fsome.com/organization/helexva-67987 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.